The curious incident of disability in multiple sclerosis trials

被引：5

作者：

Coles, Alasdair ^{[1
]}

机构：

[1] Univ Cambridge, Dept Clin Neurosci, Cambridge, England

来源：

LANCET NEUROLOGY | 2006年 / 5卷 / 11期

关键词：

D O I：

10.1016/S1474-4422(06)70585-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：899 / 900

页数：2

共 8 条

[1]

A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].

Brex, PA ;

Ciccarelli, O ;

O'Riordan, JI ;

Sailer, M ;

Thompson, AJ ;

Miller, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164

[2]

Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].

Comi, G ;

Filippi, M ;

Barkhof, F ;

Durelli, L ;

Edan, G ;

Fernández, O ;

Hartung, HP ;

Seeldrayers, P ;

Sorensen, PS ;

Rovaris, M ;

Martinelli, V ;

Hommes, OR .

LANCET, 2001, 357 (9268) :1576-1582

[3]

Preventing multiple sclerosis? [J].

Ebers, GC .

LANCET, 2001, 357 (9268) :1547-1547

[4]

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial [J].

Filippi, M ;

Rovaris, M ;

Inglese, M ;

Barkhof, F ;

De Stefano, N ;

Smith, S ;

Comi, G .

LANCET, 2004, 364 (9444) :1489-1496

[5]

Interferons in relapsing remitting multiple sclerosis: a systematic review [J].

Filippini, G ;

Munari, L ;

Incorvaia, B ;

Ebers, GC ;

Polman, C ;

D'Amico, R ;

Rice, GPA .

LANCET, 2003, 361 (9357) :545-552

[6]

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].

Jacobs, LD ;

Beck, RW ;

Simon, JH ;

Kinkel, RP ;

Brownscheidle, CM ;

Murray, TJ ;

Simonian, NA ;

Slasor, PJ ;

Sandrock, AW .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904

[7]

KAPPOS CH, 2006, NEUROLOGY, DOI DOI 10.1212/01.WNL.0000237641.33768.8D

[8]

Kinkel RP, 2006, NEUROLOGY, V66, P678

← 1 →